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Abstract Spatiotemporal information about biomole-
cules is indispensable for precise pathological analysis, but
it remains largely unclear. Here we show a novel analytical
platform combing mass spectrometry imaging (MSI) with
its complementary technique, liquid chromatography–mass
spectrometry (LC–MS), to elucidate more comprehensive
metabolic behaviors, with spatiotemporal information, in
tissues. Analysis of a rat transient middle cerebral artery
occlusion (MCAO) brain tissue after ischemia–reperfusion
was performed to characterize the detailed metabolomic
response to pathological alterations. To compare the spa-
tially resolved metabolic state between ischemic and con-
tralateral hemispheres of the MCAO brain, coronally sliced
tissues were subjected to MSI. We also measured the
metabolites extracted from three different cerebral regions,
including whole cortex (CTX), hippocampus (HI) and
corpus striatum (CPu), by LC–MS. In the ischemic hemi-
sphere, significant metabolic changes at the CTX and CPu
were observed after reperfusion, while not at the HI. A
region-specific metabolic behavior was observed in amino
acid and nucleotide metabolism, as well as in the TCA
cycle. Correlation between MSI and LC–MS data was
relatively high in the CTX and CPu. Combination of both
MS platforms visualized the diverse spatiotemporal meta-
bolic dynamics during pathological progress. Thus, our
proposed strategy will contribute to the understanding of
the complex pathogenesis of ischemia–reperfusion.
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Stroke is the third major cause of death in the major
industrialized countries, and is a brain disease associated
with cell death due to a decrease in oxygen and glucose
resulting from a lack of blood flow (ischemia) (Green
2008). The symptoms of this disease are caused by both
blood flow blockage-induced occlusion injury and oxida-
tive stress-induced reperfusion injury (Memezawa et al.
1992b; Martin 2003). To date, several therapeutic agents,
including edaravone, have been developed to lessen the
ischemia-induced damage. However, the efficacy of such
agents was limited for treating acute ischemic stroke
patients, because of the limited time window (*3 h after
ischemia) (Zhang et al. 2005). Therefore, the development
of drugs with a longer or later time window or that function
via other mechanisms is necessary.
Previous research addressing the mechanisms of disease,
including stroke, have been targeted to particular genes,
proteins and metabolites, and the analysis of only a part of
the functions related to these biomolecules has been the
focus of most investigations (Phillis et al. 1994, 1996).
However, the data obtained from such studies is insuffi-
cient to understand the complex disease processes using
conventional techniques alone, because various other, un-
targeted, biomolecules may participate in the pathological
progress (Jung et al. 2011). Behaviors of biomolecules are
drastically altered by the time elapsed from disease onset,
and there are often local differences within the lesion site
(Matsumoto et al. 1993). Therefore, to obtain a precise
understanding of the biological complexity of disease
progression, it is necessary to obtain more comprehensive
and spatiotemporal information about the biomolecules in
the target site.
Recently, ‘‘omics’’ technology, the analysis of compre-
hensive biomolecules, has received considerable attention.
In particular, metabolomics, the analysis of comprehensive
metabolites as a compound-level phenotype of genomic
information, can elucidate the biological phenomena
unresolved by transcriptomics and proteomics (Griffin and
Shockcor 2004; Holmes et al. 2008; Nicholson et al. 1999).
Generally, mass spectrometry (MS), coupled with pre-
separation techniques such as liquid chromatography (LC)–
MS or gas chromatography MS, has been used for the
metabolomic studies due to their high coverage (more than
several hundred metabolites) and ability to provide quan-
tification (Dun and Ellis 2005; Werner et al. 2008; Major
et al. 2006; Pohjanen et al. 2007). However, these methods
have a drawback in the analysis of tissue samples because
of the requirements for metabolite extraction, which causes
the loss of information regarding the spatial localization of
the metabolites. Visualization of the in situ interactions
among a broad range of metabolites and their dynamic
changes with information about their localization is indis-
pensable for accurately understanding complex biological
processes. In the pathological analysis of tissues with many
functional compartments, such as the brain, it is necessary
to not only determine the comprehensive metabolites
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involved in these processes, but also to visualize their
spatial distribution within the tissue.
A remarkable new technology, MS imaging (MSI),
enables the determination of the distribution of biomole-
cules present in tissue sections by direct ionization and
detection (Caprioli et al. 1997; Miura et al. 2012). This
technique can detect various biomolecules simultaneously
without any labeling during a single analysis. Therefore,
MSI is now being widely used for the in situ imaging of
relatively abundant macromolecules, such as proteins,
peptides and lipids, and is expected to be a potential tool
for the pathological analysis of the brain, kidneys or tumors
(Stoeckli et al. 2001; Amstalden et al. 2010; Vickerman
2011).
We recently succeeded in simultaneously visualizing
more than 30 metabolites in normal mouse brain tissue by
using matrix-assisted laser desorption/ionization-time of
flight (MALDI-TOF)-MSI (Miura et al. 2010b). Moreover,
the application of this technique and metabolic pathway
analysis to a rat transient middle cerebral artery (MCA)
occlusion (MCAO) model allowed for partially visualizing
the spatiotemporal behavior of metabolites in the central
metabolic pathway regulated by the ischemia–reperfusion
insult (Miura et al. 2010b). This MSI technique is expected
to be useful as an innovative multi-molecular imaging
technique for high-precision pathological evaluation (Kin-
ross et al. 2011). Therefore, an additional understanding of
the dynamics of more comprehensive metabolites detected
by LC–MS, which cannot be detected by MSI, may lead to
further elucidation of the complex pathological mecha-
nisms underlying various diseases.
In the present study, we performed LC–MS analysis of
metabolites extracted from MCAO rat brain, and these data
were co-analyzed with our previous and newly added MSI
data (Miura et al. 2010b) to investigate the detailed meta-
bolic dynamics during pathological progression. This
approach could trace the diverse spatiotemporal metabolic
behavior and visualize significant metabolic change in
response to disease progression in the rat brain in a model
of MCAO during infarct formation after ischemia–
reperfusion.
2 Materials and methods
2.1 Materials
Indium tin oxide (ITO)-coated slide glass and 9-aminoac-
ridine (9-AA) hydrochloride were obtained from Sigma-
Aldrich (St Louis, MO, USA). The 9-AA was recrystallized
prior to use. The organic solvents, internal standards and
metabolite standards used in this study were purchased
from Wako Pure Chemical Industries, Ltd (Osaka, Japan).
2.2 Animal protocol
Male Wistar rats (6 weeks of age) were purchased from
Kyudou (Tosu, Japan). The rats were housed in a temper-
ature- and humidity-controlled room (23 C, 78 %
humidity), and fed a commercial diet (MF; Oriental Yeast,
Tokyo, Japan) and water ad libitum. Reversible focal
cerebral ischemia was induced with an intraluminal suture
to produce a model of MCAO. In brief, anesthesia was
induced with 2 % isoflurane (Dainippon Pharmaceutical,
Osaka, Japan) in air, and was maintained with 1 % iso-
flurane using a facemask. A 1 cm midline incision was
made on the anterior neck, and the right common carotid
artery, external carotid artery and internal carotid artery
were exposed. The common carotid artery and external
carotid artery were ligated, and a suture was placed around
the internal carotid artery for ligation. An embolus was
made by inserting a 4–0 nylon surgical thread into the
internal carotid artery through a small incision. The MCA
was occluded by advancing the embolus into the internal
carotid artery to block the origin of the MCA. After 1 h of
MCAO, the MCA was reperfused by withdrawing the
embolus. The rectal temperature was maintained by plac-
ing the rat on a heating pad under anesthesia. All the
procedures and animal care were approved by the Animal
Care and Use Committee, Kyushu University, and carried
out in accordance with the Guidelines for Animal Experi-
ments, Kyushu University. Extirpated tissue samples were
immediately frozen and stored at -80 C prior to use.
2.3 MSI analysis of brain sections
In this study, we used three types of MS instruments. For
MSI, single reflectron-type MALDI-TOF-MS (AXIMA
Confidence, Shimadzu) was used. And For identification of
metabolites by MS/MS analysis, quadrupole ion trap
(QIT)-type (AXIMA QIT, Shimadzu) and TOF/TOF-type
(AXIMA Performance, Shimadzu) instruments were used.
As shown in Fig. 1a, 10 lm thick frozen coronal sections
were used for the analysis, as described previously (Miura
et al. 2010b). In the MSI experiments, the data were
acquired in negative ionization mode with 50 lm spatial
resolution (10 laser shots/data point), and the signals
between m/z 50 and 1,000 were collected. 9-AA exhibits
very few matrix-derived interferences in the low-mass
range, achieved great improvement for the sensitivity of
metabolite analysis (detection potential with sub-femto-
mole sensitivity for various endogenous metabolites) that is
advantageous for the simultaneous detection of a variety of
cellular metabolites (Miura et al. 2010a; Yukihira et al.
2010). The acquired MSI data were processed with the
freely available software program, BioMap (http://www.
maldi-msi.org). For normalization of the imaging data, we
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first constructed an averaged mass spectrum image ranging
from m/z = 50 to 1,000 over the whole region of the tissue
section. Second, averaged mass intensity maps of the
overall mass range were created. Third, averaged mass
intensity maps divided the intensity maps of each peak.
This means that the intensity of each peak in each pixel
was divided by the average of the total ion count of each
pixel. This normalization process is critical for allowing a
more quantitative comparison of the MSI data acquired
from different tissue sections, because MALDI ionization
has been known to cause both spot-to-spot and sample-to-
sample variation in the signal intensities based on the
heterogeneity of matrix crystals. The signal intensity of
each imaging data in the figure was represented as the
normalized intensity.
2.4 Metabolomic analysis of brain extracts by LC–MS
The rat brain samples were prepared 0, 3 and 24 h after
reperfusion following 1 h of MCAO. Metabolites were
extracted from the whole cortex (CTX), hippocampus (HI)
and corpus striatum (CPu) in the ischemic (Isc.) and con-
tralateral (Con.) hemispheres. Each tissue sample was
homogenized in 80 % MeOH, including 10 lM sulfanil-
amide and 2 lM 4-aminoantipyrine to evaluate the
extraction efficiency, on ice (50 mg per tissue in 1 mL
vials) using dounce tissue grinders. After centrifugation at
15,0009g for 30 min at 4 C, the supernatant was col-
lected, and an equal volume of a 2:1 H2O/CHCl3 solution
was added and further mixed vigorously for 30 s. Each
sample was then centrifuged at 15,0009g for 20 min at
4 C. After centrifugation, the aqueous layers were col-
lected. A centrifugal evaporator (CVE-2000, EYELA,
Tokyo, Japan) was used for solvent removal and sample
concentration. The resultant samples were stored at
-80 C until the analysis. Samples were dissolved in
30 lL of 20 % acetonitrile, including 10 lM 4-hydroxy-
benzophenone as an internal standard on ice, prior to the
LC–MS analysis (LCMS-IT-TOF, Shimadzu Corporation,
Kyoto, Japan). The instrument was fitted with a pentaflu-
orophenylpropyl column (Discovery HS-F5 column
250 9 4.6 mm, Supelco, Bellefonte, PA), ovened at 40 C.
The mobile phase conditions were as follows: linear gra-
dient analysis with mobile phase A (H2O with 0.1 % for-
mic acid), and mobile phase B (acetonitrile). After a 4 min
isocratic run at 100 % eluting solvent A, the ratio of eluting
solvent B was linearly increased to 35 % from 4 to 8 min
and to 50 % from 8 to 12 min. The use of 50 % eluting
solvent B was maintained for 5 min. The column was then
washed with 100 % of eluting solvent B for 5 min, and
column equilibration was carried out with 100 % eluting
solvent A for 7 min. A 3 lL aliquot of the sample solution
filtered through a 0.2 lm PTFE filter (EMD Millipore
Corporation, Billerica, MA) was injected onto the column
with a flow rate of 0.2 mL/min.
For the MS, the instrument was operated using an
electrospray ionization source in both positive and negative
ionization modes. The ionization parameters were: capil-
lary voltage, 4.5 and -3.5 kV; the nebulizer gas flow,
1.5 L/min; the CDL temperature, 250 C and the heat
block temperature, 250 C. Peak picking, alignment and
normalization of the mass spectral data obtained by LC–
MS were performed using the Profiling Solution software
program (Shimadzu Corporation, Kyoto, Japan). Identified
metabolites were quantified using authentic standards, and
then the data were expressed as the ratios (ischemic
hemisphere/contralateral hemisphere).
2.5 Multivariate statistical analysis
A principal component analysis (PCA) was performed
using the SIMCA-P? software program (Version 12,
Fig. 1 A schematic diagram of the sampling areas for the MSI and
LC–MS analyses. Rat brain tissue samples were collected 0, 3 and
24 h after reperfusion following 1 h of MCAO. A schematic
illustration represents the structures of the sagittally (a) and coronally
(b) sectioned brains. In both the contralateral (Con.) and ischemic
(Isc.) hemispheres, the whole cerebral cortex (CTX), hippocampus
(HI) and corpus striatum (CPu) were enucleated from the brain for the
LC–MS analysis. Coronal brain sections, including the CTX, CPu and
HI, were subjected to the MSI analysis
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MKS-Umetrics, Umea˚, Sweden), allowing the visualization
of LC–MS multivariate information. All variables were
centered on the average and were normalized by dividing
by the standard deviation (unit variance).
Heat maps were displayed using the freely available
software program, MultiExperiment Viewer (http://www.
tm4.org). The metabolite concentration data of LC–MS
and/or mass peak intensity data of MSI were converted to
the ratio of the Isc. hemisphere to the Con. hemisphere. A
heat map analysis was performed on the data to visualize
the metabolic dynamics.
3 Results and discussion
3.1 Experimental flow
In this study, we analyzed the metabolic dynamics in the
brain of MCAO model rats during infarct formation after
ischemia–reperfusion by integrating different MS tech-
niques (MSI and LC–MS) (Fig. S1). To reveal the differ-
ences in metabolic variations in each functional tissue
region of the brain, a metabolomic analysis of the CTX,
CPu and HI regions was performed (Fig. 1). Rat brain
samples were collected at different time intervals after
ischemia–reperfusion (0, 3 and 24 h, n = 5) to investigate
the time-dependent metabolic variations after reperfusion
following 1 h of MCAO. To compare the metabolic state in
the Isc. and Con. hemispheres of the MCAO brain
(Fig. 1b), metabolites extracted from three different whole
tissue regions (CTX, HI and CPu) were also measured by
LC–MS. The CTX, CPu and HI tissue samples were cor-
onally sectioned at 10-lm thickness, and metabolites on
these partial tissue regions were directly measured by MSI
to visualize their spatial distribution.
3.2 Global investigation of region-specific metabolic
dynamics during infarct formation
In the present study, we performed a holistic evaluation of
the metabolic profile in three regions (CTX, CPu and HI) and
in each hemisphere (Isc. or Con.) at different times after
reperfusion (0, 3 and 24 h) by a multivariate statistical ana-
lysis using LC–MS data sets (Fig. 2). We used an explor-
atory data analysis, PCA, which provides a summary or
overview of all observations or samples in the data. In
addition, groupings trends and outliers can be found easily.
In the Con. hemisphere (Fig. 2a), the cluster formation of
each region was observed, suggesting that the metabolic
states were clearly different among the three representative
compartments (CTX, CPu and HI). Such region-specific
clusters were also formed in the Isc. hemisphere, and further
time-dependent separation was observed in both the CTX
and CPu regions, unlike the HI (Fig. 2b). These results indi-
cate that the metabolic states of the CPu and CTX in the Isc.
hemisphere were different from those in the Con. hemisphere,
and that there were further time-dependent changes in
response to ischemia–reperfusion injury. It is known that the
MCA blood supply is important in both the CPu and CTX
regions, but not in the HI region (Martin 2003; Kitagawa et al.
1998). This fact may provide insight into the region-specific
metabolic alterations after ischemia–reperfusion.
Next, we investigated the variations in each metabolite
level in the CTX and CPu regions showing a significant
Fig. 2 The multivariate analysis of cerebral metabolomic changes
induced by reperfusion following 1 h MCAO. The CPu (red), HI
(blue) and CTX (green) extracts from the contralateral (a) and
ischemic hemispheres (b) at 0 h (square), 3 h (triangle) and 24 h
(circle) after reperfusion were measured by LC–MS, and the resulting
MS spectral data were subjected to an exploratory data analysis
(PCA). The separate score plot is shown for each hemisphere’s data
sets
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metabolic change in response to disease progression. With
regard to 47 common metabolites detected in both the CTX
and CPu regions, changes of their ratio (Isc./Con.) at each
time point were shown as a heat map (Fig. 3). The con-
centrations of almost all of the nucleic acids, except for
ATP, UMP and CDP-choline in the CPu and ATP and IMP
in the CTX, were reduced in a time-dependent manner. The
peak accumulation of amino acids (e.g., lysine, phenylal-
anine, arginine and histidine) was observed at 3 h after
reperfusion. The amounts of tricarboxylate cycle (TCA)
cycle intermediates, such as citrate, in the Isc. hemisphere
were sustained at higher levels compared to the Con.
hemisphere. Although many of the detected metabolites
were expressed at the same level in both hemispheres just
after reperfusion, the difference in concentrations was
clearly observed by 3 h after reperfusion. Especially at the
time point 24 h after reperfusion, the majority of the
metabolites in the CPu and CTX, except for pseudouridine
and xanthine (malate in the CPu), were significantly
reduced in the Isc. hemisphere compared with the Con.
hemisphere.
A previous study reported that the production of reactive
oxygen species (ROS) was especially increased at 1 or 2 h
after reperfusion (Sims and Muyderman 2010; Lipton
1999). The generation of ROS causes an inactivation of
metabolic enzymes and membrane lipid peroxidation
(Martin 2003; Bromont et al. 1989). Therefore, reperfusion
after 1 h MCAO may induce a failure of energy production
and result in a low energy state in the cells present in the
occluded MCA area (Sims and Muyderman 2010; Lipton
1999). Moreover, both the synthesis and degradation of
proteins are dependent on the energy status (Bylund-
Fellenius et al. 1984), and the enzymatic activity of protein
synthesis was markedly inhibited after reperfusion (Abe
et al. 1988). Hence, the above-mentioned alterations of the
amino acid level may be due to an accumulation of amino
acids as a result of the catabolism of proteins resulting from
the inhibition of protein synthesis. Furthermore, it was
already known that the activity of glucose-6-phosphate
dehydrogenase in the pentose phosphate pathway, which
generates nicotinamide adenine dinucleotide phosphate
(NADPH) and ribose-5-phosphate for nucleotide synthesis,
is reduced after reperfusion of the MCA (Yousuf et al.
2009; Sarkar and Das 2006). Such an alteration of enzy-
matic activity may cause a reduction in the overall nucleic
acid level (Fig. 3). Taken together, these results raised the
possibility that changes in the blood flow during MCA
occlusion and reperfusion were associated with the region-
specific metabolic behavior involved in the reduction of
both energy production and related enzymatic activity.
Although many metabolite levels after reperfusion showed
similar alterations in the CTX and CPu regions, the variation
pattern of particular metabolites, such as malate, was clearly
different (Fig. 3). A high concentration of citrate was sus-
tained at the CPu in the Isc. hemisphere during reperfusion (0,
3 and 24 h), but the citrate level in the CTX showed a time-
dependent accumulation. The metabolic response in the CTX
was partially delayed compared with that in the CPu. A pre-
vious study reported that a decrease in the blood flow occurred
over the whole region of the CPu following occlusion of the
MCA, and that the medial area of the anterior CPu had rela-
tively mild ischemia (blood flow rate: 50 %) (Memezawa
et al. 1992a). On the other hand, the CTX is finely separated
into several functional regions (Fig. S2) and its blood flow is
supplied via multiple arteries, including the MCA. Therefore,
Fig. 3 Heat map visualization of the common metabolites identified
in two brain components during ischemia–reperfusion. Data were
obtained by the average intensity ratio (ischemic hemisphere/contra-
lateral hemisphere) from the LC–MS analysis. The data of 47
common metabolites detected in the CTX and CPu were visualized.
The normalized mean values were displayed using the MultiExper-
iment Viewer (http://www.tm4.org). The colored letters for the heat
map are as follows: amino acids (red), central metabolism interme-
diates (blue), nucleic acids (green), other metabolites (orange)
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the occlusion of the MCA causes a heterogeneous biological
regulation in different functional regions of the CTX. The
blood flow rate in the cingulate cortex was not significantly
reduced by occlusion of the MCA, whereas the rates in the
neocortex and piriform cortex were markedly decreased
(Memezawa et al. 1992a). Moreover, the parietal cortex and
somatosensory cortex, one of the neocortex-constructed
regions, exhibited serious ischemia (blood flow rate: 15 %),
while both other neocortex areas (e.g. the parietal cortex,
motor area) and piriform cortex exhibited modest ischemia
(blood flow rate: 20 %) (Memezawa et al. 1992a). These
circumstances may thus help to explain the differences
between the CPu and CTX regions in terms of the time-
dependent metabolic dynamics during reperfusion.
3.3 Comparison of the metabolic variations
between the whole tissue region and its micro-
regions in the MCAO rat brain after ischemia–
reperfusion
Generally, an LC–MS analysis is able to detect and deter-
mine many kinds of metabolites, but the resulting data are
averaged information from the whole tissue because of the
extraction step. Tissue samples consisting of several func-
tional compartments, such as brain, may have different
metabolic regulation within smaller compartments contained
within the single target region. Hence, the LC–MS technique
may not correctly trace characteristic metabolic states during
a pathological progress. To elucidate accurate and region-
specific metabolic changes induced by ischemia–reperfu-
sion, it is necessary to visualize the spatiotemporal meta-
bolic behavior at the micro-regional scale.
To investigate spatially-resolved metabolic dynamics in
micro-regions of the CPu and CTX, we used brain tissue
sections (Fig. 1b) for MALDI-MSI, which enabled us to
simultaneously detect multiple biomolecules with two-
dimensional local information (Miura et al. 2010b).
Although a part of the MSI data was already reported (Miura
et al. 2010b), we compared the intensities of metabolite
peaks between MSI and LC–MS. In the LC–MS analysis,
the metabolites were extracted from whole CTX or CPu
region in both the Isc. and Con. hemispheres, and the
metabolite concentrations were averaged for each whole
region (Fig. 1a). As shown in Fig. 1a, we prepared 10 lm
brain slices, including the central portions of the ischemic
lesions. The signal intensity of each metabolite within each
region of interest (CTX (green) and CPu (red) as shown in
Fig. 1b) was averaged, and then the data were used for the
assessment of region-specific changes in the metabolite
levels.
The data for 12 metabolites commonly detected by both
LC–MS and MSI were examined by a heat map analysis
(Fig. 4). Although some partial MSI data were already
published (Miura et al. 2010b), a further data analysis was
performed in this study. Each data was expressed as the
ratio of the Isc. hemisphere to the Con. hemisphere. Similar
behaviors of several metabolite levels were observed
between the MSI and LC–MS data, although the intensity
ratios were different. In particular, the time-dependent
changes in N-acetyl aspartate (NAA) were similar to those
of glycerol-3-phosphate (glycerol-3P) and citrate in the
CPu and CTX regions in both analytical platforms.
On the other hand, the correlations between the data
acquired by two different platforms were low for fructose
1,6-bisphosphate (F16P) (CPu and CTX), glutamate and
aspartate (CPu), and UDP-glucose (CTX). The coronally
sliced tissue samples of MSI contained the central portions
of the ischemic lesions, and the obtained data directly
reflect the metabolic change during ischemia–reperfusion
in the tissue micro-region level (i.e., highly resolved spatial
information of the target region). In contrast, the data from
LC–MS were averaged information of the whole region
that contained the non-ischemic area. Therefore, the dif-
ferent metabolic events between the analytical platforms
may be due to the different metabolic changes between the
affected area and its peripheral area. The temporal
expression patterns of citrate and glycerol-3P after reper-
fusion in the CPu and CTX were highly correlated between
the MSI and LC–MS data. In the CPu, such metabolite
concentrations were similar between the platforms,
although these concentrations were clearly different in the
CTX. The metabolism in the whole region of the CPu is
relatively homogeneously regulated by the MCA, whereas
many micro-regions of the CTX are not. We speculate that
the differences in the regulation of blood flow between
CTX and CPu regions may have contributed to the dif-
ferences between the LC–MS and MSI data. The LC–MS
data at least relatively reflected the time-dependent meta-
bolic changes shown by MSI. Therefore, the information
about the metabolites detected by LC–MS, but not by MSI,
may lead to an understanding of the spatial characteristics
of the metabolic state in response to pathological
progression.
3.4 Spatiotemporal metabolomic dynamics
and metabolic pathway analysis by combing MSI
and LC–MS
As described above, we found several properties of both
MS platforms in the metabolomic analysis. To expand this
knowledge to a pathological evaluation, we applied this
technique to visualize more comprehensive spatiotemporal
metabolic dynamics in the pathogenesis of ischemia–
reperfusion injury (Fig. 5). The MSI data, indicating the
time-dependent changes in the metabolite distribution at 0,
3 and 24 h after reperfusion, are shown in Fig. 5a. A
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quantitative comparison (the ratio of the Isc. hemisphere to
the Con. hemisphere) of time-dependent metabolite varia-
tions in molecules related to glycolysis, the TCA cycle,
nucleotide and amino acid metabolism in the CPu and CTX
was performed by using LC–MS (Fig. 5b). By integrating
the highly quantitative data obtained from LC–MS and the
spatially resolved data obtained from MSI, we could
investigate the spatiotemporal metabolic variance.
With regard to the pyrimidine metabolism, in the MSI
analysis, a significant decrease in uridine diphosphate
(UDP) and UDP-glucose was observed over the whole
region of the Isc. hemisphere 24 h after reperfusion
(Fig. 5a, No. 11 and 12). In the LC–MS analysis, a
reduction of UDP derivatives (UDP and UDP-glucose), as
well as peripheral metabolites (cytidine diphosphate
(CDP)-choline, phosphoethanolamine (PE), and N-acety-
lneuraminate (Neu5Ac)), was observed at 24 h. Previously,
it was reported that the production of ROS was increased
during ischemia, and its level was further elevated with the
onset of reperfusion, and finally, the generated ROS were
able to cause injury to the plasma membranes, thus leading
to cell death (Bromont et al. 1989). The reduced levels of
membrane intermediates, such as PE, CDP-choline, UDP
and UDP-glucose, may have been due to their consumption
for plasma membrane synthesis to restore the membrane
integrity following ROS-mediated damage.
The levels of many amino acids, the catabolites of
proteins, were increased, except for glutamate, which is
related to various metabolic reactions, after 3 h of reper-
fusion in the Isc. hemisphere (Fig. 5b). The inhibition of
protein synthesis and the progression of protein degrada-
tion after reperfusion have been reported previously
(Bylund-Fellenius et al. 1984; Neumar 2000). Although
MSI data alone cannot explain the characteristic behavior
of amino acids, the above-mentioned protein alterations
after reperfusion probably contribute to the accumulation
of the building blocks of proteins 3 h after reperfusion.
MSI also showed a significant increase in the aspartate
level in the whole regions of the Isc. hemisphere after 3 h
of reperfusion (Fig. 5a, No.6). In this study, MSI was not
able to trace most of the amino acids measured by LC–MS.
However, our findings that the LC–MS data exhibited a
relatively high correlation with the MSI data (Fig. 4)
suggest that amino acids showing a similar behavior to
aspartate in the LC–MS results may show an aspartate-like
distribution in the Isc. hemisphere, although further studies
are needed to confirm whether this is the case.
On the other hand, the levels of almost all amino acids,
including glutamate, were reduced at 24 h (Fig. 5b). The
energy production was reported to be depressed after
reperfusion due to the inactivation of TCA cycle-related
enzymes, aconitase and 2-oxoglutarate dehydrogenase,
resulting from the hypergeneration of ROS (Tretter and
Adam 2000). In addition, we previously found that citrate
synthase activity was not affected by ischemia–reperfusion
(Miura et al. 2010b). The LC–MS analysis in the present
study also showed that TCA cycle intermediates, citrate
(CPu and CTX) and malate (CPu), were accumulated in the
Isc. hemisphere after reperfusion. These observations raise
a possibility that the reduction of amino acids may be
partially due to their utilization as TCA cycle intermediates
for reactivation of the TCA cycle. The MSI data also
revealed that the increase in citrate, as well as the decrease
in aspartate and glutamate after 24 h of reperfusion were
Fig. 4 A comparison of the average intensity between the whole
tissue regions and partial tissue regions. The average intensity of the
whole tissue region is represented as the average intensity ratio
(ischemic hemisphere/contralateral hemisphere) for each whole tissue
region (LC–MS data, see Fig. 1a). The regional average intensity of a
partial tissue region is represented as the average intensity of each
region on 10 lm slices (MSI data, see Fig. 1b). In the heat map, 12
common metabolites detected by LC–MS and MSI were visualized.
The normalized mean values were displayed using the MultiExper-
iment Viewer (http://www.tm4.org). The colored letters for the heat
map are as follows: amino acids (red), central metabolism interme-
diates (blue), nucleic acids (green), other metabolites (orange)
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Fig. 5 The integrated MSI and LC–MS techniques allow the
visualization of drastic changes in the spatiotemporal metabolite
distribution. a In situ MSI visualized dramatic changes in the
spatiotemporal metabolite distribution in the MCAO rat brain.
Metabolites related to nucleotide and amino acid metabolism, as
well as the central pathway, were simultaneously visualized in a
single MSI experiment. Scale bar 1.0 mm. Data (No. 1–7) were
reprinted with permission from the author (Miura et al. 2010b).
b Comparative visualization of the central metabolic pathway and its
peripheral metabolic pathways in the CPu (upper box, red) and CTX
(lower box, green) in the MCAO rat brain, as determined by LC–MS.
Significant differences (Student’s t test, *P \ 0.05) are indicated by
asterisks on the colored boxes. Black and grey letters indicate LC–
MS-detected metabolites and unmeasured metabolites, respectively.
Green letters indicate metabolites detected by both LC–MS and MSI.
Solid arrows represent a single step connecting two metabolites, and
dotted arrows represent multiple steps
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characteristically heterogeneously distributed in the Isc.
hemisphere (Fig. 5a, No. 4–6).
As previously mentioned in the description of the LC–
MS-based metabolic profiling (Fig. 2), the blood supply of
the brain is provided via not only the MCA, but also sev-
eral other arteries (such as the anterior and posterior
cerebral arteries). The artery-regulated region is not nec-
essarily consistent with each functional compartment. In
fact, the blood supply of the CTX is regulated by both the
MCA and other arteries. Intriguingly, the region with the
most characteristic metabolic variation (citrate, aspartate
and glutamate) shown by MSI was relatively consistent
with the specific region demonstrating remarkable lower-
ing of the blood flow by occlusion of the MCA (Kitagawa
et al. 1998).
4 Concluding remarks
In the present study, we were able to visualize diverse
spatiotemporal metabolic dynamics within the central
metabolic pathway and its periphery in the MCAO rat brain
during infarct formation using an integrated technique
combining MSI with LC–MS. Using representative tissue
samples of different functional compartments, LC–MS was
used to trace the temporal changes of many metabolites
which could not be visualized by MSI. Significant meta-
bolic changes in the blood supplying area from the MCA
were observed by a series of region-specific behavioral
analyses. To date, conventional pathological analysis of
MCAO models has not shown the spatiotemporal meta-
bolic behaviors after reperfusion. In contrast, we herein
visualized a MCA-regulated metabolic change in several
metabolic pathways, including the pyrimidine-, amino
acid- and TCA cycle-related metabolism, during patho-
logical progression. Thus, our new approach combining
MSI (spatial information but low coverage) and its com-
plementary technique LC–MS (high coverage but loss of
spatial information) will provide insight into the under-
standing of the complex pathological mechanism(s) of
ischemia–reperfusion injury. This could be broadly appli-
cable to emerging issues in the precise pathological eval-
uation of target tissues in both preclinical and clinical
settings, and may become a compulsory technique for
in situ pharmacometabolomics and biomarker discovery.
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